Published in Eur Radiol on June 01, 2012
Quantitative MR Imaging in Locally Advanced Cervical Cancer (IQ-EMBRACE) | NCT03210428
Diffusion-weighted MRI characteristics of the cerebral metastasis to brain boundary predicts patient outcomes. BMC Med Imaging (2014) 0.98
Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients. Korean J Radiol (2013) 0.85
Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy. BMC Cancer (2015) 0.83
Time-window of early detection of response to concurrent chemoradiation in cervical cancer by using diffusion-weighted MR imaging: a pilot study. Radiat Oncol (2015) 0.83
Clinical applications for diffusion magnetic resonance imaging in radiotherapy. Semin Radiat Oncol (2014) 0.81
Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study. BMC Cancer (2015) 0.77
Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies. Cancer Imaging (2015) 0.76
A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer. Radiat Oncol (2016) 0.75
Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells. Biosci Rep (2016) 0.75
Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient. Onco Targets Ther (2016) 0.75
Prognostic potential of initial CT changes for progression-free survival in gefitinib-treated patients with advanced adenocarcinoma of the lung: a preliminary analysis. Eur Radiol (2015) 0.75
Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors. Eur Radiol (2017) 0.75
The value of advanced MRI techniques in the assessment of cervical cancer: a review. Insights Imaging (2017) 0.75
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol (2007) 6.80
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet (2001) 5.71
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A (2005) 4.63
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84
Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging (2006) 2.26
Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer (1996) 2.20
Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia (2005) 2.17
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol (2009) 2.10
Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology (2010) 1.98
Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol (2009) 1.83
Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol (2004) 1.74
Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol (2007) 1.60
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys (2003) 1.57
Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology (2009) 1.56
Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.55
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia (2007) 1.50
Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results. Int J Radiat Oncol Biol Phys (2009) 1.43
Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol (2010) 1.42
Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol (2000) 1.41
Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol (2008) 1.39
Diffusion-weighted MRI in cervical cancer. Eur Radiol (2008) 1.34
Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia (2004) 1.32
Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res (2007) 1.31
Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy. AJNR Am J Neuroradiol (2002) 1.29
Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol (2010) 1.15
The utility of diffusion-weighted MR imaging in cervical cancer. Eur J Radiol (2009) 1.07
A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study. Oncol Rep (2008) 1.00
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis. Eur J Gynaecol Oncol (2008) 0.93
Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol (2008) 0.90
Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys (2008) 0.90
Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy. J Gynecol Oncol (2010) 0.84
Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr (2008) 0.78
Using MR imaging to predict and evaluate the response of invasive cervical carcinoma to systemic chemotherapy. AJR Am J Roentgenol (1998) 0.75
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ (2004) 4.22
Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol (2002) 3.29
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J Natl Cancer Inst (2004) 2.66
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
NICE's cost effectiveness threshold. BMJ (2007) 2.49
Mammographic breast density: comparison of methods for quantitative evaluation. Radiology (2015) 2.22
A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ (2003) 2.10
Case of tuberculosis of the temporomandibular joint. Br J Oral Maxillofac Surg (2011) 2.01
Five-year follow-up of patients undergoing laparoscopic or open groin hernia repair: a randomized controlled trial. Ann Surg (2002) 1.64
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer (2007) 1.62
Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data. Health Econ (2010) 1.52
Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol (2010) 1.49
Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol (2013) 1.45
Monitoring primary breast cancer throughout chemotherapy using FDG-PET. Breast Cancer Res Treat (2006) 1.44
Is the aim of the English health care system to maximize QALYs? J Health Serv Res Policy (2012) 1.42
Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol (2008) 1.39
Evidence-based radiology: why and how? Eur Radiol (2010) 1.38
Patients' views of explicit rationing: what are the implications for health service decision-making? J Health Serv Res Policy (2003) 1.32
B1 transmission-field inhomogeneity and enhancement ratio errors in dynamic contrast-enhanced MRI (DCE-MRI) of the breast at 3T. J Magn Reson Imaging (2010) 1.25
Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. Radiology (2005) 1.24
Searching for cost effectiveness thresholds in the NHS. Health Policy (2009) 1.23
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. Clin Transl Oncol (2009) 1.15
Solitary fibrous tumor of the liver expressing CD34 and vimentin: a case report. World J Gastroenterol (2008) 1.13
The relationship between vascular and metabolic characteristics of primary breast tumours. Eur Radiol (2004) 1.11
The DAMASK trial protocol: a pragmatic randomised trial to evaluate whether GPs should have direct access to MRI for patients with suspected internal derangement of the knee. BMC Health Serv Res (2006) 1.11
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials. Eur Radiol (2012) 1.09
A longitudinal MRI study of muscle atrophy during lower leg immobilization following ankle fracture. J Magn Reson Imaging (2011) 1.06
Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view. Breast Cancer Res (2008) 1.03
BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res (2007) 1.02
Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study. Parkinsonism Relat Disord (2013) 1.00
Improving response rates using a monetary incentive for patient completion of questionnaires: an observational study. BMC Med Res Methodol (2007) 0.99
Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual Life Res (2013) 0.98
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev (2012) 0.98
Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging (2013) 0.96
The effect of axial load on the sagittal plane curvature of the upright human spine in vivo. J Biomech (2008) 0.95
Identifying the impact of government targets on waiting times in the NHS. Health Care Manag Sci (2009) 0.94
Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett (2004) 0.94
Loss to follow-up after total hip replacement: a source of bias in patient reported outcome measures and registry datasets? Hip Int (2014) 0.94
Characterizing the shape of the lumbar spine using an active shape model: reliability and precision of the method. Spine (Phila Pa 1976) (2008) 0.90
Estimating the costs of conflict and containment on adult acute inpatient psychiatric wards. Nurs Econ (2008) 0.90
The effect of perceived risks on the demand for vaccination: results from a discrete choice experiment. PLoS One (2013) 0.89
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study. Strahlenther Onkol (2005) 0.89
Perimetric progression in open angle glaucoma and the Visual Field Index (VFI). J Glaucoma (2011) 0.88
Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH). Cochrane Database Syst Rev (2013) 0.88
Standardising measurement of tumour vascularity by imaging: recommendations for ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography. Eur Radiol (2012) 0.87
Truly inefficient or providing better quality of care? Analysing the relationship between risk-adjusted hospital costs and patients' health outcomes. Health Econ (2012) 0.87
A test of performance of breast MRI interpretation in a multicentre screening study. Magn Reson Imaging (2006) 0.87
In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature. Breast Cancer Res (2012) 0.86
Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening study. Radiology (2006) 0.86
Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol (2005) 0.86
Funding fertility: issues in the allocation and distribution of resources to assisted reproduction technologies. Hum Fertil (Camb) (2003) 0.86
Using postal randomization to replace telephone randomization had no significant effect on recruitment of patients. J Clin Epidemiol (2007) 0.86
Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review. Eur Radiol (2011) 0.85
The intrinsic shape of the human lumbar spine in the supine, standing and sitting postures: characterization using an active shape model. J Anat (2009) 0.85
Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation. Anticancer Res (2007) 0.85
The impact of laparoscopic Nissen fundoplication on the long-term quality of life in patients with gastroesophageal reflux disease. Gastroenterol Nurs (2015) 0.85
A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2009) 0.85
Is computer aided detection (CAD) cost effective in screening mammography? A model based on the CADET II study. BMC Health Serv Res (2011) 0.85
The effects of humming and pitch on craniofacial and craniocervical morphology measured using MRI. J Voice (2011) 0.84
Recognising diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. A response to Sculpher and Gafni. Health Econ (2002) 0.84
Mammographic features of breast cancers at single reading with computer-aided detection and at double reading in a large multicenter prospective trial of computer-aided detection: CADET II. Radiology (2010) 0.83
Inter-provider comparison of patient-reported outcomes: developing an adjustment to account for differences in patient case mix. Health Econ (2013) 0.83
WHO evaluates NICE. BMJ (2003) 0.83
Quantification techniques to minimize the effects of native T1 variation and B1 inhomogeneity in dynamic contrast-enhanced MRI of the breast at 3 T. Magn Reson Med (2011) 0.82
Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature. Anticancer Res (2005) 0.82
Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study. Med Oncol (2004) 0.82
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm. Cancer Imaging (2010) 0.81
3D MRI analysis of the lower legs of treated idiopathic congenital talipes equinovarus (clubfoot). PLoS One (2013) 0.81
Predicting the response of advanced cervical and ovarian tumors to therapy. Obstet Gynecol Surv (2009) 0.80
Bone metastasis from epithelial ovarian carcinoma. Lancet Oncol (2002) 0.79
Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial). Radiology (2010) 0.79
Evaluation of perifacet injections and paraspinal muscle rehabilitation in treatment of low back pain. A randomised controlled trial. Ortop Traumatol Rehabil (2012) 0.78
Using databases in medical education research: AMEE Guide No. 77. Med Teach (2013) 0.78
Relationship between service ecology, special observation and self-harm during acute in-patient care: City-128 study. Br J Psychiatry (2008) 0.78
Assessment of the apparent diffusion coefficient (ADC) of normal breast tissue during the menstrual cycle at 3T using image segmentation. Eur J Radiol (2012) 0.77
Magnetic resonance imaging in gynecological oncology. Int J Gynecol Cancer (2009) 0.77
Changes in foetal liver T2* measurements by MRI in response to maternal oxygen breathing: application to diagnosing foetal growth restriction. Physiol Meas (2010) 0.76
Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer. J Magn Reson Imaging (2014) 0.76
Correlation of MRI/PET rim enhancement in breast cancer: a delivery related phenomenon with therapy implications? Lancet Oncol (2003) 0.76
Efficiency and productivity change in the English National Health Service: can data envelopment analysis provide a robust and useful measure? J Health Serv Res Policy (2003) 0.75
Positron emission tomography oncology research in the UK: a comparison with USA and Europe. Nucl Med Commun (2012) 0.75
Response to "Tuberculosis of the temporomandibular joint: part of a bigger picture". Br J Oral Maxillofac Surg (2012) 0.75
11β-Hydroxysteroid dehydrogenase activity in the brain does not contribute to systemic interconversion of cortisol and cortisone in healthy men. J Clin Endocrinol Metab (2014) 0.75
Response. Radiology (2015) 0.75
Roundtable discussion. Appraise be. Health Serv J (2005) 0.75
Relationships between vocal structures, the airway, and craniocervical posture investigated using magnetic resonance imaging. J Voice (2011) 0.75
The cost of microwave endometrial ablation under different anaesthetic and clinical settings. BJOG (2003) 0.75
Impact of physiological noise correction on detecting blood oxygenation level-dependent contrast in the breast. Phys Med Biol (2016) 0.75
Bilateral long ureteral strictures, as an early complication, following short-term preoperative pelvic radiotherapy for rectal carcinoma. Acta Oncol (2002) 0.75
Turning therapies: placing medical diversity. Med Anthropol (2014) 0.75
Building PET research collaborations. Nucl Med Commun (2012) 0.75
Increasing participant recruitment into large-scale screening trials: experience from the CADET II study. J Med Screen (2009) 0.75
Positron emission tomography radiopharmaceutical studies in humans: a guide to regulations for academic researchers. Nucl Med Commun (2012) 0.75